DOUGLAS FALLER

Dirigeant

OtherM

ES·CNMV

Oryzon Genomics, S.A.ORYZON GENOMICS, S.A.ORYZON GENOMICS SA Oryzon Genomics SA

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by DOUGLAS FALLER, Dirigeant. Insider active across 4 companies, notably Oryzon Genomics, S.A.. In total, 2 reports have been logged. The latest transaction was disclosed on 6 February 2024 — Other. Regulator: CNMV. The full history is openly available.

Declarations2 total

Executives●OtherOORYZON GENOMICS SA24CNMV

D

DOUGLAS FALLERDIRECTOR MEDICO GENERAL

€16,35015,000 shares@ €1.090.0070% mcap100.0% of flow

ShareXOOF

CNMV:2024020824·6 Feb 2024

CNMV ↗

Executives●OtherOOryzon Genomics, S.A.25CNMV

D

DOUGLAS FALLERDIRECTOR MEDICO GENERAL

€25,60010,000 shares@ €2.560.011% mcap100.0% of flow

ShareXOOF

CNMV:2023022698·9 Feb 2023

CNMV ↗

2 of 2 declarations

About DOUGLAS FALLER

Douglas Faller is the Chief Medical Officer at Oryzon Genomics, S.A. He is responsible for medical strategy and overseeing clinical operations, contributing to innovation in the biopharmaceutical sector.